Lifecore Biomedical
LFCR
LFCR
97 hedge funds and large institutions have $279M invested in Lifecore Biomedical in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1% less funds holding
Funds holding: 98 → 97 (-1)
Holders
97
Holding in Top 10
5
Calls
$575K
Puts
–
Top Buyers
| 1 | +$4.49M | |
| 2 | +$3.65M | |
| 3 | +$1.33M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$979K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$921K |
Top Sellers
| 1 | -$7.82M | |
| 2 | -$4.46M | |
| 3 | -$2.83M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.16M |
| 5 |
BlackRock
New York
|
-$623K |